Studies
In 2008, EMHA carried out its first ‘Access to Care’ survey among the migraine patient community to learn more on the availability of migraine treatments and the access to them in each country.Â
In 2021, EMHA carried out a second ‘Access to Care‘ survey to see if any progress had been made. The survey was circulated by EMHA’s member associations in 11 EU countries and the UK to get an overview on the hurdles patients have to overcome to get a diagnosis and treatment. The survey identifies what still needs to be done to improve the migraineurs’ quality of life and make them full part of society.
Regrettably, the 2021 survey results do not show any improvement in the management of migraine in the EU since 2008.
This prompts EMHA to reinforce its policy advocacy campaign to make migraine a EU and national health priority.Â
EMHA’s Call to Action (launched in 2020) and Statement (launched in 2021) are the two policy advocacy tools that pave the way to improve the quality of life of migraineurs and make society more migraine-friendly.
Let’s act together now!
Statistical data
EUROPE
STATS BY GENDER​
No Data Found
STATS BY AGE
No Data Found
STATS BY TYPE​
No Data Found
SEE BY COUNTRY:
STATS BY GENDER​
No Data Found
STATS BY AGE
No Data Found
STATS BY TYPE​
No Data Found
STATS BY GENDER​
No Data Found
STATS BY AGE
No Data Found
STATS BY TYPE​
No Data Found
STATS BY GENDER​
No Data Found
STATS BY AGE
No Data Found
STATS BY TYPE​
No Data Found
STATS BY GENDER​
No Data Found
STATS BY AGE
No Data Found
STATS BY TYPE​
No Data Found
STATS BY GENDER​
No Data Found
STATS BY AGE
No Data Found
STATS BY TYPE​
No Data Found
STATS BY GENDER​
No Data Found
STATS BY AGE
No Data Found
STATS BY TYPE​
No Data Found
STATS BY GENDER​
No Data Found
STATS BY AGE
No Data Found